Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 132,055,823	$ 125,044,092
Inventories	1,694,765	1,494,891
Finance lease receivables, current – related parties	7,281,088	5,992,585
Customer loans receivable, current	8,903,724	10,382,537
Prepaid expenses and other current assets	32,970,169	11,276,802
Total current assets	215,096,937	184,451,020
Non-current assets:
Property and equipment, net	8,523,351	8,771,902
Intangible assets, net	1,543,779	1,590,052
Goodwill, net	4,780,616	4,613,784
Finance lease receivables, non-current – related parties	10,648,402	8,397,582
Operating lease right-of-use assets	5,152,104	5,267,056
Finance lease right-of-use assets	522,055
Deferred tax assets	2,513,653	9,798,071
Customer loans receivable, non-current	4,525,883	5,023,551
Long-term prepayments	1,922,709	1,745,801
Other assets	6,980,816	15,553,453
Total non-current assets	69,508,852	81,632,134
Total assets	284,605,789	266,083,154
Current liabilities:
Current portion of long-term loans	66,950	96,824
Notes and other payables, current – related parties	1,422,976	26,255
Income tax payable	1,624,002	18,705,851
Operating lease liabilities, current	4,131,154	4,341,522
Finance lease liabilities, current	157,532
Accrued liabilities and other current liabilities	8,564,250	8,103,194
Total current liabilities	48,466,216	61,191,890
Non-current liabilities:
Long-term loans	6,798,045	6,502,682
Notes and other payables, non-current – related parties	12,413	5,334
Deferred tax liabilities	346,432	926,023
Operating lease liabilities, non-current	1,312,819	1,241,526
Finance lease liabilities, non-current	195,572
Other liabilities	1,151,857	1,193,541
Total non-current liabilities	9,817,138	9,869,106
Total liabilities	58,283,354	71,060,996
Stockholders’ equity:
Preferred stock ($0.0001 par value, 20,000,000 shares authorized; no shares issued and outstanding as of March 31, 2025 and December 31, 2024)
Common stock ($0.0001 par value, 400,000,000 shares authorized, 103,881,251 and 103,020,816 shares issued, 103,611,251 and 102,750,816 shares outstanding as of March 31, 2025 and December 31, 2024, respectively)	10,388	10,302
Additional paid-in capital	62,513,837	62,513,923
Treasury stock (at cost, 270,000 shares as of March 31, 2025 and December 31, 2024)	(2,700,000)	(2,700,000)
Retained earnings	210,965,453	189,463,007
Accumulated other comprehensive loss	(44,343,412)	(54,178,075)
Total SBC Medical Group Holdings Incorporated stockholders’ equity	226,446,266	195,109,157
Non-controlling interests	(123,831)	(86,999)
Total stockholders’ equity	226,322,435	195,022,158
Total liabilities and stockholders’ equity	284,605,789	266,083,154
Nonrelated Party [Member]
Current assets:
Accounts receivable	1,633,456	1,413,433
Non-current assets:
Long-term investments	3,703,699	3,049,972
Current liabilities:
Accounts payable	17,854,422	13,875,179
Advances from customers	525,497	820,898
Related Party [Member]
Current assets:
Accounts receivable	30,557,912	28,846,680
Non-current assets:
Long-term investments	18,691,785	17,820,910
Current liabilities:
Accounts payable	1,141,762	659,044
Advances from customers	10,155,134	11,739,533
Due to related party	$ 2,822,537	$ 2,823,590